Belimumab

Category: Immune System



Belimumab Overview

Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF),[4] also known as B-lymphocyte stimulator (BLyS).[5] It is approved in the United States,[6] Canada,[7] and Europe[3] to treat systemic lupus erythematosus (SLE). The most common side effects include bacterial infections, such as bronchitis (infection in the lungs) and infection of the urinar...

Read more Belimumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Belimumab

Recent Belimumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Belimumab
  • Injection: 120mg, 200mg/ml, 400mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Belimumab or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 5 December 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA